Form 4: Sabra Health Care REIT Executive VP, CFO & Secretary Michael Lourenco Costa Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reports acquisition of 2,624 shares of common stock and adjustments to holdings in IRA accounts.
Summary
- On August 30, 2024, Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reported changes in beneficial ownership of the company's common stock.
- Costa acquired 2,624 shares of common stock.
- These shares were acquired at a price of $0.
- Following the transaction, Costa directly owns 252,850 shares of common stock.
- Costa also indirectly owns 784 shares through a Reporting Person's IRA and 207 shares through a Reporting Person's Spouse's IRA.
- The report also includes an exhibit for Power of Attorney, granting authority to Richard K. Matros, Andor D. Terner, Shelly Heyduk, Mollie Yeh and Regina Braman to act on Costa's behalf in SEC filings.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by an executive is generally a positive sign, but the document primarily reflects routine regulatory filings.
Positives
- The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the acquisition of shares by an executive could imply a positive outlook.
Industry Context
This filing is a routine disclosure related to insider trading and is common for publicly traded companies. It provides transparency into the transactions of company executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| June 13, 2024 | Date of Power of Attorney execution. |
| August 30, 2024 | Date of transaction (acquisition of common stock). |
| September 04, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.